Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04338399
Title The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC (BURAN)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Adlai Nortye Biopharma Co., Ltd.
Indications

head and neck squamous cell carcinoma

Therapies

Buparlisib + Paclitaxel

Paclitaxel

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Hope Cancer Center, UT Health East Texas Recruiting Tyler Texas 75701 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field